Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Benicar
Synonyms :
Class :
Antihypertensives; Angiotensin Receptor Blockers
Brand Name :
Benicar
Synonyms :
Class :
Antihypertensives; Angiotensin Receptor Blockers
Dosage forms & Strengths:
Adult:
Tablet:
5 mg
20 mg
40 mg
20
mg/day
Orally
; increased to 40 mg after 2 weeks
Following may be Diuretic added
Not recommended for children below 6 years
For children above 6 years:
10-20 mg each day orally each day
Age: 6-16 yrs:
Body weight 20-35 kg: 10 mg/day orally daily; increase up to 20 mg after 2 weeks if there is inadequate response
Body weight >35 kg: 20 mg/day orally daily; increase up to 40 mg after 2 weeks if there is inadequate response
do not exceed 40 mg/day
5-10 mg each day initially; increase up to 40 mg/day after 2 weeks if required
angiotensin II Receptor Blockers may enhance the adverse/toxic effect of angiotensin-Converting Enzyme Inhibitors
angiotensin II Receptor Blockers may enhance the adverse/toxic effect of angiotensin-Converting Enzyme Inhibitors
angiotensin II Receptor Blockers may enhance the adverse/toxic effect of angiotensin-Converting Enzyme Inhibitors
angiotensin II Receptor Blockers may enhance the adverse/toxic effect of angiotensin-Converting Enzyme Inhibitors
angiotensin II Receptor Blockers may enhance the adverse/toxic effect of angiotensin-Converting Enzyme Inhibitors
may Increase the adverse effect of NSAIDs
may Increase the adverse effect of NSAIDs
may Increase the adverse effect of NSAIDs
may Increase the adverse effect of NSAIDs
may Increase the adverse effect of NSAIDs
It may diminish the serum concentration when combined with colesevelam
may have an increasingly adverse effect when combined with ACE inhibitors
may have an increasingly adverse effect when combined with ACE inhibitors
may have an increasingly adverse effect when combined with ACE inhibitors
may have an increasingly adverse effect when combined with ACE inhibitors
may have an increasingly adverse effect when combined with ACE inhibitors
may have an increased adverse effect when combined with angiotensin-converting enzyme inhibitors
may have an increased adverse effect when combined with angiotensin-converting enzyme inhibitors
may have an increased adverse effect when combined with angiotensin-converting enzyme inhibitors
may have an increased adverse effect when combined with angiotensin-converting enzyme inhibitors
may increase the adverse effect of angiotensin II receptor blockers
may increase the adverse effect of angiotensin II receptor blockers
may increase the adverse effect of angiotensin II receptor blockers
may increase the adverse effect of angiotensin II receptor blockers
may increase the adverse effect of angiotensin II receptor blockers
may increase the adverse effect of angiotensin ii receptor blockers
may increase the adverse effect of angiotensin ii receptor blockers
may increase the adverse effect of angiotensin ii receptor blockers
may increase the adverse effect of angiotensin ii receptor blockers
may increase the adverse effect of angiotensin ii receptor blockers
lithium: they may enhance the serum concentration of Angiotensin II Receptor antagonist
ay increase the hyperkalemic effect of aliskiren
may increase the adverse effect of angiotensin ii receptor blockers
may increase the adverse effect of angiotensin ii receptor blockers
may increase the adverse effect of angiotensin ii receptor blockers
may enhance the serum concentration of angiotensin ii receptor blockers
may enhance the serum concentration of angiotensin ii receptor blockers
it increases the toxicity of angiotensin II receptor blockers
spironolactone and hydrochlorothiazide
may have an increased hyperkalemic effect when combined with potassium-sparing diuretics
may have an increased hyperkalemic effect when combined with potassium-sparing diuretics
may have an increased hyperkalemic effect when combined with potassium-sparing diuretics
may have an increased hyperkalemic effect when combined with potassium-sparing diuretics
may have an increased hyperkalemic effect when combined with potassium-sparing diuretics
may have an increasingly adverse effect when combined with NSAIDs
it increases the effect of hyperkalemia of angiotensin II receptor blockers
it enhances the serum potassium levels
may enhance the effects of the other by pharmacodynamic synergism
may increase the toxic effect of non-steroidal anti-inflammatory drugs
dapoxetine: they may increase the orthostatic hypotensive effect of Angiotensin II Receptor antagonists
Nonsteroidal Anti-Inflammatory Agents: they may decrease the therapeutic effect of Angiotensin II Receptor antagonist
Nonsteroidal Anti-Inflammatory Agents: they may decrease the therapeutic effect of Angiotensin II Receptor antagonist
Nonsteroidal Anti-Inflammatory Agents: they may decrease the therapeutic effect of Angiotensin II Receptor antagonist
Nonsteroidal Anti-Inflammatory Agents: they may decrease the therapeutic effect of Angiotensin II Receptor antagonist
Nonsteroidal Anti-Inflammatory Agents: they may decrease the therapeutic effect of Angiotensin II Receptor antagonist
may have an increased hyperkalemic effect when combined with angiotensin ii receptor blockers
may have an increased hyperkalemic effect when combined with angiotensin ii receptor blockers
may have an increased hyperkalemic effect when combined with angiotensin ii receptor blockers
1-10%:
Dizziness
Hyperglycemia
Hypertriglyceridemia
Rhinitis
Sinusitis
Back pain
Bronchitis
Diarrhea
Headache
Fatigue
Inflicted injury
Flulike symptoms
Pharyngitis
Respiratory tract infection
Frequency undefined:
Anaphylactic reaction
Angioedema
Gastroenteritis
Facial edema
Hyperkalemia
Tachycardia
Rhabdomyolysis
Hypercholesterolemia
Olmesartan is contraindicated in patients hypersensitive to the formulation’s active ingredient and other excipients.
Pregnancy consideration:
Not indicated for usage in pregnant women
Breastfeeding warnings:
The drug excretion in breastmilk is unknown
Pregnancy category:
Patient information leaflet
Generic Name: olmesartan
Pronounced: olme-sar-tan
Why do we use olmesartan?
Olmesartan treats hypertension.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
